OBJECTIVE: We determined the rate of falls among cognitively normal, community-dwelling older adults, some of whom had presumptive preclinical Alzheimer disease (AD) as detected by in vivo imaging of fibrillar amyloid plaques using Pittsburgh compound B (PiB) and PET and/or by assays of CSF to identify Aβ₄₂, tau, and phosphorylated tau. METHODS: We conducted a 12-month prospective cohort study to examine the cumulative incidence of falls. Participants were evaluated clinically and underwent PiB PET imaging and lumbar puncture. Falls were reported monthly using an individualized calendar journal returned by mail. A Cox proportional hazards model was used to test whether time to first fall was associated with each biomarker and the ratio of CSF tau/Aβ₄₂ and CSF phosphorylated tau/Aβ₄₂, after adjustment for common fall risk factors. RESULTS: The sample (n = 125) was predominately female (62.4%) and white (96%) with a mean age of 74.4 years. When controlled for ability to perform activities of daily living, higher levels of PiB retention (hazard ratio = 2.95 [95% confidence interval 1.01-6.45], p = 0.05) and of CSF biomarker ratios (p < 0.001) were associated with a faster time to first fall. CONCLUSIONS: Presumptive preclinical AD is a risk factor for falls in older adults. This study suggests that subtle noncognitive changes that predispose older adults to falls are associated with AD and may precede detectable cognitive changes.
OBJECTIVE: We determined the rate of falls among cognitively normal, community-dwelling older adults, some of whom had presumptive preclinical Alzheimer disease (AD) as detected by in vivo imaging of fibrillar amyloid plaques using Pittsburgh compound B (PiB) and PET and/or by assays of CSF to identify Aβ₄₂, tau, and phosphorylated tau. METHODS: We conducted a 12-month prospective cohort study to examine the cumulative incidence of falls. Participants were evaluated clinically and underwent PiB PET imaging and lumbar puncture. Falls were reported monthly using an individualized calendar journal returned by mail. A Cox proportional hazards model was used to test whether time to first fall was associated with each biomarker and the ratio of CSFtau/Aβ₄₂ and CSF phosphorylated tau/Aβ₄₂, after adjustment for common fall risk factors. RESULTS: The sample (n = 125) was predominately female (62.4%) and white (96%) with a mean age of 74.4 years. When controlled for ability to perform activities of daily living, higher levels of PiB retention (hazard ratio = 2.95 [95% confidence interval 1.01-6.45], p = 0.05) and of CSF biomarker ratios (p < 0.001) were associated with a faster time to first fall. CONCLUSIONS: Presumptive preclinical AD is a risk factor for falls in older adults. This study suggests that subtle noncognitive changes that predispose older adults to falls are associated with AD and may precede detectable cognitive changes.
Authors: Joe Verghese; Richard B Lipton; Charles B Hall; Gail Kuslansky; Mindy J Katz; Herman Buschke Journal: N Engl J Med Date: 2002-11-28 Impact factor: 91.245
Authors: William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström Journal: Ann Neurol Date: 2004-03 Impact factor: 10.422
Authors: Joseph T Hanlon; Lawrence R Landerman; Gerda G Fillenbaum; Stephanie Studenski Journal: J Gerontol A Biol Sci Med Sci Date: 2002-07 Impact factor: 6.053
Authors: Randall J Bateman; Chengjie Xiong; Tammie L S Benzinger; Anne M Fagan; Alison Goate; Nick C Fox; Daniel S Marcus; Nigel J Cairns; Xianyun Xie; Tyler M Blazey; David M Holtzman; Anna Santacruz; Virginia Buckles; Angela Oliver; Krista Moulder; Paul S Aisen; Bernardino Ghetti; William E Klunk; Eric McDade; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Peter R Schofield; Reisa A Sperling; Stephen Salloway; John C Morris Journal: N Engl J Med Date: 2012-07-11 Impact factor: 91.245
Authors: Neelesh K Nadkarni; Oscar L Lopez; Subashan Perera; Stephanie A Studenski; Beth E Snitz; Kirk I Erickson; Chester A Mathis; Robert D Nebes; Mark Redfern; William E Klunk Journal: J Gerontol A Biol Sci Med Sci Date: 2017-03-01 Impact factor: 6.053
Authors: Chun Liang Hsu; John R Best; Bryan K Chiu; Lindsay S Nagamatsu; Michelle W Voss; Todd C Handy; Niousha Bolandzadeh; Teresa Liu-Ambrose Journal: Exp Gerontol Date: 2016-04-11 Impact factor: 4.032
Authors: Gilles Allali; Cyrille P Launay; Helena M Blumen; Michele L Callisaya; Anne-Marie De Cock; Reto W Kressig; Velandai Srikanth; Jean-Paul Steinmetz; Joe Verghese; Olivier Beauchet Journal: J Am Med Dir Assoc Date: 2016-11-30 Impact factor: 4.669
Authors: Julie K Wisch; Catherine M Roe; Ganesh M Babulal; Suzanne E Schindler; Anne M Fagan; Tammie L Benzinger; John C Morris; Beau M Ances Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Abayomi N Ogunwale; Cathleen S Colon-Emeric; Richard Sloane; Robert A Adler; Kenneth W Lyles; Richard H Lee Journal: J Bone Miner Res Date: 2019-12-12 Impact factor: 6.741
Authors: Lynn Rochester; Brook Galna; Sue Lord; Alison J Yarnall; Rosie Morris; Gordon Duncan; Tien K Khoo; Brit Mollenhauer; David J Burn Journal: Neurology Date: 2017-03-22 Impact factor: 9.910